AbCellera Biologics (ABCL) Short Interest Ratio & Short Volume $2.85 -0.07 (-2.40%) (As of 03:15 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AbCellera Biologics Short Interest DataAbCellera Biologics (ABCL) has a short interest of 16.64 million shares, representing 8.04% of the float (the number of shares available for trading by the public). This marks a -4.09% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.1, indicating that it would take 8.1 days of the average trading volume of 1.68 million shares to cover all short positions.Current Short Interest16,640,000 sharesPrevious Short Interest17,350,000 sharesChange Vs. Previous Month-4.09%Dollar Volume Sold Short$45.43 millionShort Interest Ratio8.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares295,370,000 sharesFloat Size207,080,000 sharesShort Percent of Float8.04%Today's Trading Volume1,910,972 sharesAverage Trading Volume1,681,570 sharesToday's Volume Vs. Average114% Short Selling AbCellera Biologics? Sign up to receive the latest short interest report for AbCellera Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartABCL Short Interest Over TimeABCL Days to Cover Over TimeABCL Percentage of Float Shorted Over Time Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover AbCellera Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202416,640,000 shares $45.43 million -4.1%8.0%8.1 $2.73 10/15/202417,350,000 shares $44.42 million +1.7%8.4%9.4 $2.56 9/30/202417,060,000 shares $44.36 million +1.3%8.3%9.8 $2.60 9/15/202416,840,000 shares $46.31 million -4.1%8.2%9 $2.75 8/31/202417,550,000 shares $44.93 million -3.4%8.5%9.2 $2.56 8/15/202418,170,000 shares $47.61 million +4.3%8.8%10.7 $2.62 Get the Latest News and Ratings for ABCL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AbCellera Biologics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202417,420,000 shares $56.79 million -2.0%8.4%10.6 $3.26 7/15/202417,770,000 shares $56.86 million -5.4%8.6%10.7 $3.20 6/30/202418,780,000 shares $55.59 million -4.8%9.1%11.5 $2.96 6/15/202419,720,000 shares $63.70 million +7.1%9.6%13.1 $3.23 5/31/202418,420,000 shares $72.21 million -6.7%8.9%14.6 $3.92 5/15/202419,750,000 shares $73.08 million -15.2%9.6%14.6 $3.70 4/30/202423,290,000 shares $88.04 million +0.9%11.3%16.8 $3.78 4/15/202423,090,000 shares $96.52 million -2.1%11.3%17.4 $4.18 3/31/202423,590,000 shares $106.86 million +2.4%11.5%16.7 $4.53 3/15/202423,040,000 shares $108.52 million +1.1%11.2%16 $4.71 2/29/202422,780,000 shares $115.04 million -0.1%11.1%14.8 $5.05 2/15/202422,810,000 shares $120.44 million -6.9%11.4%14.6 $5.28 1/31/202424,490,000 shares $125.14 million -2.3%12.3%16.8 $5.11 1/15/202425,070,000 shares $135.13 million -2.0%12.6%16.6 $5.39 12/31/202325,580,000 shares $146.06 million -3.2%12.9%16.7 $5.71 12/15/202326,420,000 shares $143.46 million -2.2%13.3%16.9 $5.43 11/30/202327,000,000 shares $127.17 million -1.7%13.6%16.8 $4.71 11/15/202327,470,000 shares $124.44 million -1.2%13.9%17.8 $4.53 10/31/202327,810,000 shares $114.30 million +5.5%14.0%17 $4.11 10/15/202326,370,000 shares $112.34 million +2.5%13.4%15 $4.26 9/30/202325,720,000 shares $118.31 million +1.7%13.0%13.6 $4.60 9/15/202325,290,000 shares $135.05 million -4.2%12.8%12.4 $5.34 8/31/202326,390,000 shares $143.83 million -4.2%13.4%10 $5.45 8/15/202327,550,000 shares $152.08 million +4.3%14.0%9.2 $5.52 7/31/202326,410,000 shares $204.15 million +4.9%13.4%8.3 $7.73 7/15/202325,170,000 shares $180.22 million -0.3%12.8%8.1 $7.16 6/30/202325,240,000 shares $163.05 million -12.9%12.8%8.7 $6.46 6/15/202328,960,000 shares $216.62 million +11.5%14.7%10.3 $7.48 5/31/202325,970,000 shares $181.01 million -2.4%13.2%12 $6.97 5/15/202326,620,000 shares $159.19 million +8.5%13.5%13.5 $5.98 4/30/202324,530,000 shares $166.31 million +4.0%12.5%14.1 $6.78 4/15/202323,590,000 shares $174.09 million +0.1%12.0%14.9 $7.38 3/31/202323,560,000 shares $177.64 million +2.2%12.0%14.4 $7.54 3/15/202323,050,000 shares $171.26 million +4.0%11.8%13.6 $7.43Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide 2/28/202322,170,000 shares $186.23 million +9.0%11.3%12 $8.40 2/15/202320,340,000 shares $202.99 million +6.3%10.5%10.9 $9.98 1/31/202319,130,000 shares $201.44 million -2.8%9.9%10.1 $10.53 1/15/202319,680,000 shares $204.28 million +29.9%10.1%9.8 $10.38 12/30/202215,150,000 shares $153.47 million -1.3%7.8%7.6 $10.13 12/15/202215,350,000 shares $159.64 million -7.0%7.9%7.6 $10.40 11/30/202216,510,000 shares $212.48 million -7.3%8.5%8.7 $12.87 11/15/202217,800,000 shares $257.92 million -2.4%9.2%10.3 $14.49 10/31/202218,230,000 shares $215.66 million -6.7%9.4%10 $11.83 10/15/202219,530,000 shares $201.94 million +0.6%10.1%11.1 $10.34 9/30/202219,410,000 shares $191.96 million -10.2%10.1%10.6 $9.89 9/15/202221,620,000 shares $235.23 million +7.8%11.6%9.6 $10.88 8/31/202220,050,000 shares $214.13 million +3.7%10.8%7.7 $10.68 8/15/202219,340,000 shares $261.86 million +1.0%10.4%7.2 $13.54 7/31/202219,140,000 shares $192.17 million -0.5%10.3%7 $10.04 7/15/202219,230,000 shares $202.68 million +0.2%10.3%7.3 $10.54 6/30/202219,200,000 shares $204.48 million +56.5%10.3%7.5 $10.65 6/15/202212,270,000 shares $113.74 million +13.9%6.6%4.9 $9.27 5/31/202210,770,000 shares $82.07 million -9.9%5.8%5.8 $7.62 5/15/202211,950,000 shares $86.40 million +2.0%6.4%6.5 $7.23 4/30/202211,720,000 shares $89.89 million -9.1%6.2%6.8 $7.67 4/15/202212,890,000 shares $115.88 million +7.2%6.9%6.8 $8.99 3/31/202212,030,000 shares $117.29 million +5.5%6.4%5.8 $9.75 3/15/202211,400,000 shares $88.58 million +8.5%6.1%5.6 $7.77 2/28/202210,510,000 shares $91.54 million -11.5%5.6%4.8 $8.71 2/15/202211,880,000 shares $118.56 million -2.5%6.4%5.5 $9.98 1/31/202212,190,000 shares $109.59 million -3.6%7.2%5.8 $8.99 1/15/202212,650,000 shares $127.13 million +19.7%7.6%6.4 $10.05 12/31/202110,570,000 shares $151.15 million +9.8%6.3%5.8 $14.30 12/15/20219,630,000 shares $125.09 million -14.2%5.8%4.9 $12.99 11/30/202111,220,000 shares $167.85 million +7.3%6.7%4.8 $14.96 11/15/202110,460,000 shares $171.44 million -1.4%6.3%4.5 $16.39 10/29/202110,610,000 shares $166.68 million +5.2%6.5%4.3 $15.71 10/15/202110,090,000 shares $156.70 million +24.3%6.2%4.2 $15.53 9/30/20218,120,000 shares $162.72 million +3.3%5.0%3.3 $20.04 9/15/20217,860,000 shares $147.85 million +1.6%4.8%3.3 $18.81 8/31/20217,740,000 shares $129.88 million -26.2%4.8%3.7 $16.78 8/13/202110,490,000 shares $187.67 million +22.7%6.6%5.1 $17.89 7/30/20218,550,000 shares $129.70 million +0.2%5.5%4.9 $15.17 7/15/20218,530,000 shares $141.00 million +1.8%5.3%5.3 $16.53 6/30/20218,380,000 shares $184.36 million +17.7%5.2%5.3 $22.00 6/15/20217,120,000 shares $167.53 million -6.1%4.5%4.7 $23.53 5/28/20217,580,000 shares $203.37 million -10.1%5.1%6.4 $26.83 5/14/20218,430,000 shares $287.80 million +31.9%5.6%7.9 $34.14 4/30/20216,390,000 shares $183.90 million +8.3%4.3%5.9 $28.78 4/15/20215,900,000 shares $166.68 million -4.8%3.9%5.6 $28.25 3/31/20216,200,000 shares $165.42 million +53.9%4.1%5.7 $26.68 3/15/20214,030,000 shares $147.26 million +79.9%2.7%4.4 $36.54 2/26/20212,240,000 shares $87.49 million -23.0%1.5%1.9 $39.06 2/12/20212,910,000 shares $133.86 million -37.3%2.0%2.4 $46.00Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide 1/29/20214,640,000 shares $238.96 million -6.1%3.1%3.6 $51.50 1/15/20214,940,000 shares $230.40 million No Change3.2%3.4 $46.64 ABCL Short Interest - Frequently Asked Questions What is AbCellera Biologics' current short interest? Short interest is the volume of AbCellera Biologics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 16,640,000 shares of ABCL short. 8.04% of AbCellera Biologics' shares are currently sold short. Learn More on AbCellera Biologics' current short interest. What is a good short interest ratio for AbCellera Biologics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABCL shares currently have a short interest ratio of 8.0. Learn More on AbCellera Biologics's short interest ratio. What is a good short interest percentage for AbCellera Biologics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.04% of AbCellera Biologics' floating shares are currently sold short. Is AbCellera Biologics' short interest increasing or decreasing? AbCellera Biologics saw a drop in short interest in October. As of October 31st, there was short interest totaling 16,640,000 shares, a drop of 4.1% from the previous total of 17,350,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is AbCellera Biologics' float size? AbCellera Biologics currently has issued a total of 295,370,000 shares. Some of AbCellera Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AbCellera Biologics currently has a public float of 207,080,000 shares. How does AbCellera Biologics' short interest compare to its competitors? 8.04% of AbCellera Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to AbCellera Biologics: Verona Pharma plc (9.35%), HUTCHMED (China) Limited (0.33%), Zai Lab Limited (4.68%), ACADIA Pharmaceuticals Inc. (5.73%), Dyne Therapeutics, Inc. (9.90%), MorphoSys AG (0.09%), Catalyst Pharmaceuticals, Inc. (5.84%), Janux Therapeutics, Inc. (10.18%), Protagonist Therapeutics, Inc. (5.50%), Arrowhead Pharmaceuticals, Inc. (7.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short AbCellera Biologics stock? Short selling ABCL is an investing strategy that aims to generate trading profit from AbCellera Biologics as its price is falling. ABCL shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AbCellera Biologics? A short squeeze for AbCellera Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABCL, which in turn drives the price of the stock up even further. How often is AbCellera Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABCL, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Verona Pharma Short Squeeze HUTCHMED Short Squeeze Zai Lab Short Squeeze ACADIA Pharmaceuticals Short Squeeze Dyne Therapeutics Short Squeeze MorphoSys Short Squeeze Catalyst Pharmaceuticals Short Squeeze Janux Therapeutics Short Squeeze Protagonist Therapeutics Short Squeeze Arrowhead Pharmaceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ABCL) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbCellera Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbCellera Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
